Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo

Cell and Tissue Research

Volumn 356, Issue 1, 2014, Pages 109-121

  Bai, Yan ^a,b   Leng, Yue ^a   Yin, Guangfu ^a   Pu, Ximing ^a   Huang, Zhongbing ^a   Liao, Xiaoming ^a   Chen, Xianchun ^a   Yao, Yadong ^a  

^a SICHUAN UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; BMP 2; FGF 2; VEGF

Indexed keywords

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CHICKENS; CHORIOALLANTOIC MEMBRANE; FIBROBLAST GROWTH FACTOR 2; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PHYSIOLOGIC; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84898849170     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-013-1781-9     Document Type: Article

References (36)

1. Akhtar N, Dickerson EB, Auerbach R (2002) The sponge/Matrigel angiogenesis assay. Angiogenesis 5:75-80
2. Bai Y, Li PP, Yin GF, Huang ZB, Liao XM, Chen XC, Yao YD (2013) BMP-2, VEGF and bFGF synergistically promote the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. Biotechnol Lett 35:301-308
3. Ball SG, Shuttleworth CA, Kielty CM (2007) Vascular endothelial growth factor can through platelet-derived growth factor receptors. J Cell Biol 177:489-500
4. Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V, Le Bourhis X (2000) FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev 11:295-302
5. Bouïs D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA (2006) A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53:89-103
6. Calori GM, Donati D, Di Bella C, Tagliabue L (2009) Bone morphogenetic proteins and tissue engineering: future directions. Injury 40:67-76
7. Carano RA, Filvaroff EH (2003) Angiogenesis and bone repair. Drug Discov Today 8:980-989
8. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395
9. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
10. Chambers RC, Leoni P, Kaminski N, Laurent GJ, Heller RA (2003) Global expression profiling of fibroblast responses to transforming growth factor-β (1) reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 162:533-546
11. Chen JH, Wang XC, Kan M, Sato JD (2001) Effect of FGF-1 and FGF-2 on VEGF binding to human umbilical vein endothe-lial cells. Cell Biol Int 25:257-260
12. Cunningham NS, Paralkar V, Reddi AH (1992) Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor h1 mRNA expression. Proc Natl Acad Sci USA 89:11740-11744
13. David L, Feige JJ, Bailly S (2009) Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20:203-212
14. Dimitriou R, Tsiridis E, Giannoudis PV (2005) Current concepts of molecular aspects of bone healing. Injury 36:1392-1404
15. Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O (2003) Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 47:149-161
16. Finkenzeller G, Hager S, Stark GB (2012) Effects of bone morphogenetic protein 2 on human umbilical vein endothelial cells. Microvasc Res 84:1-85
17. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
18. Fujita M, Ishihara M, Simizu M, Obara K, Ishizuka T, Saito Y, Yura H, Morimoto Y, Takase B, Matsui T, Kikuchi M, Maehara T (2004) Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials 25:699-706
19. Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, Cheresh DA (2008) A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456:809-813
20. He C, Chen X (2005) Transcription regulation of the VEGF gene by the BMP/Smad pathway in the angioblast of zebrafish embryos. Biochem Biophys Res Commun 329:324-330
21. Hoeben A, Landuyt B, Martin S, Highley HW, Van Oosterom AT, De Bruijn EA (2004) Vascular Endothelial Growth Factor and Angiogenesis. Pharmacol Rev 56:549-580
22. Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685-693
23. Kanczler JM, Ginty PJ, White L, Clarke NMP, Howdle SM, Shakesheff KM, Oreffo ROC (2010) The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31:1242-1250
24. Langenfeld EM, Langenfeld J (2004) Bone Morphogenetic Protein-2 Stimulates Angiogenesis in Developing Tumors. Mol Cancer Res 2:141-149
25. Lee KY, Peters MC, Mooney DJ (2003) Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release 21:49-56
26. Lei H, Juan AH, Kim M-S, Ruddle FH (2006) Identification of a Hoxc8-regulated transcriptional network in mouse embryo fibroblast cells. Dev Biol 103:10305-10309
27. Mandriota SJ, Pepper MS (1997) Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci 110:2293-2302
28. Marrony S, Bassilana F, Seuwen K, Keller H (2003) Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells. Bone 33:426-433
29. Nillesen STM, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH (2007) Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 28:1123-1131
30. Nilsson M, Heymach JV (2006) Vascular Endothelial Growth Factor (VEGF) Pathway. J Thorac Oncol 1:768-770
31. Pallares J, Rojo F, Iriarte J, Morote J, Armadans LI, de Torres I (2006) Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues. Histol Histopathol 21:857-865
32. Pepper MS (1997) Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21-43
33. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2005) Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16:159-178
34. Schlatter P, Konig MF, Karlsson LM, Burri PH (1997) Quantitative Study of Intussusceptive Capillary Growth in the Chorioallantoic Membrane (CAM) of the Chicken Embryo. Microvasc Res 54:65-73
35. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P (1998) Fibroblast growth factor-2 (FGF-2) induces vascular growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659-1673
36. Valdes TI, Kreutzer D, Moussy F (2007) The chick chorioallantoic membrane as a novel in vivo model for the testing of biomaterials. J Biomed Mater Res 62:273-282